Joseph C. Lewis
Tavistock Group http://www.tavistock.com/Joseph C. Lewis is a British billionaire and founder of Tavistock Group. Lewis remains the single largest investor in Tavistock Group, a private investment company whose portfolio consists of 170 companies in the private residential and resort properties, master planned development, financial services, life sciences, manufacturing and distribution, sports and entertainment, and restaurant industries.
Lewis had a $1 billion stake in Bear Stearns before it imploded in March 2008.
View Older Stories View More Recent Stories
-
Nuvalent Completes $135 Million Series B Financing to Advance Portfolio of Novel Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
-
Twist Brands to Debut First Dual-Brand Painting with a Twist & Color Me Mine Studio
-
Hitachi Social Innovation Forum 2021 AMERICAS to Showcase How Data Driven Leaders are Changing the World
-
Boundless Bio Raises Oversubscribed $105 Million Series B Financing to Advance Next-Generation Precision Oncology Therapies Directed Against Extrachromosomal DNA (ecDNA)
-
Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies
-
Asher Bio Launches with $55 Million Series A Financing Led by Third Rock Ventures to Discover and Develop Highly Specific Immunotherapies Using a Novel Technology Platform
-
Nuvation Bio Reports Full Year 2020 Financial Results and Provides Business Update
-
Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs
-
Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company
-
Gemini Therapeutics (GMTX) Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular Degeneration
-
Gemini Therapeutics Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular Degeneration
-
New Channels Honoring Aretha Franklin, Jimi Hendrix, Miles Davis, and Motown Launch on SiriusXM Today
-
Dream Finders Homes (DFM) Acquires Century Homes Florida, LLC
-
Dream Finders Homes Acquires Century Homes Florida, LLC
-
Dream Finders Homes Acquires Century Homes Florida, LLC
-
CiVi Biopharma to Participate in HC Wainwright BioConnect 2021 Conference
-
Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing
-
Biomea Fusion Raises $56 Million to Bring First Irreversible Menin Inhibitor into the Clinic and Advance Two Additional Irreversible Preclinical Programs
-
Cullinan Oncology Completes $131.2 Million Series C Financing
-
Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway
-
Brooks Rehabilitation to Open a Rehabilitation Hospital in Lake Nona
-
Clean Republic Expands Its Smart Clean Movement With Consumer Launch Of Its EPA And ECHA-Approved Disinfectant + Sanitizer
-
Thrilling Teen Fiction Highlighted in LibraryBub Selection for December
-
Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours
-
Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours
-
Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours
-
Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
-
FASTSIGNS International, Inc. CEO to Deliver Keynote at International Franchise Association's Emerging Franchisor Virtual Event
-
Verizon Business 5G Innovation Hub in Lake Nona to Explore 5G-Enabled Solutions Across a Number of Industries
-
Verizon Business 5G Innovation Hub in Lake Nona to Explore 5G-Enabled Solutions Across a Number of Industries
-
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
-
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
-
Painting with a Twist's Parent Company Acquires Color Me Mine and Chesapeake Ceramics
-
Tim Draper Backs Startup PORTL Hologram in $3M Seed Round
-
Nuvation Bio and Panacea Announce Business Combination Agreement, Creating a Publicly Listed Leader in Oncology Drug Development
-
Gemini Therapeutics and FS Development Corp. Announce Merger Agreement Creating Publicly Listed Precision Medicine Company Focused on Age-Related Macular Degeneration
-
Cedilla Therapeutics Announces $57.6 Million Series B Financing
-
Samsung Fails to Dismiss Twelve Alleged Employment Claims, According to ILG Legal Office, PC
-
CiVi Biopharma Resumes AURORA Phase 3 Clinical Trial of CIVI030 to Treat Systemic Sclerosis
-
Blank Check Company LifeSci Acquisition Corp. (LSAC) Announces Merger Agreement with Vincera Pharma, Inc.
-
LifeSci Acquisition Corp. Announces Merger Agreement with Vincera Pharma, Inc. to Create New Publicly Listed Oncology Company
-
Watch Kane Brown get beamed to the iHeartRadio Music Festival via PORTL Hologram
-
Silverback Therapeutics Raises $85 Million in Series C Financing; Company Announces Executive Promotions
-
SuperYacht Times Features Bobby Genovese's Storied Feadship, BG Charade
-
Unum Therapeutics Inc. (UMRX) Transfers BOXR Cell-Based Therapy Technology to SOTIO
-
Unum Therapeutics Transfers BOXR Cell-Based Therapy Technology to SOTIO
-
Kinnate Biopharma Closes $98 Million Series C Financing
-
Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs
-
Tango Therapeutics Announces $50 Million Equity Financing
-
PMV Pharma Closes $70 Million in Series D Financing

